We are live on ! Find out more
TCM

Traynor Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 62.36%
This Fund
S&P 500
This Quarter Est. Return
+5.92%
1 Year Est. Return
+62.36%
3 Year Est. Return
+225.14%
5 Year Est. Return
+309.6%
10 Year Est. Return
+1,325.66%
AUM
$210M
AUM Growth
+$7.69M
Cap. Flow
+$4.27M
Cap. Flow %
2.03%
Top 10 Hldgs %
44.48%
Holding
178
New
16
Increased
72
Reduced
69
Closed
10

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$840K
2
AAPL icon
Apple
AAPL
+$728K
3
MO icon
Altria Group
MO
+$501K
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$439K
5
SNAP icon
Snap
SNAP
+$408K

Top Sells

Rank Stock Value
1
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$516K
2
AMZN icon
Amazon
AMZN
+$363K
3
QCOM icon
Qualcomm
QCOM
+$343K
4
VMC icon
Vulcan Materials
VMC
+$287K
5
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$239K

Sector Composition

Rank Sector Weight
1 Technology 11.78%
2 Communication Services 11.14%
3 Healthcare 9.45%
4 Consumer Discretionary 7.27%
5 Industrials 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCN
126
PIMCO Corporate & Income Strategy Fund
PCN
$874M
$265K 0.13%
15,404
-2,618
-15% -$45K
EUXL
127
DELISTED
Direxion Daily EURO STOXX 50 Bull 3X Shares
EUXL
$260K 0.12%
+8,975
New +$243K
EG icon
128
Everest Group
EG
$14.1B
$258K 0.12%
1,077
-169
-14% -$42.6K
GE icon
129
GE Aerospace
GE
$387B
$257K 0.12%
2,236
-434
-16% -$52.5K
SDIV icon
130
Global X SuperDividend ETF
SDIV
$1.22B
$253K 0.12%
3,851
+204
+6% +$13.3K
BIVV
131
DELISTED
Bioverativ Inc. Common Stock
BIVV
$244K 0.12%
4,307
-39
-0.9% -$2.28K
IWC icon
132
iShares Micro-Cap ETF
IWC
$1.5B
$241K 0.11%
2,570
-211
-8% -$18.6K
TXT icon
133
Textron
TXT
$15.1B
$238K 0.11%
4,459
-49
-1% -$2.43K
EXEL icon
134
Exelixis
EXEL
$14.1B
$236K 0.11%
9,750
-400
-4% -$10.6K
PG icon
135
Procter & Gamble
PG
$341B
$236K 0.11%
2,604
+3
+0.1% +$273
CAT icon
136
Caterpillar
CAT
$403B
$231K 0.11%
1,844
-709
-28% -$81.7K
BIB icon
137
ProShares Ultra NASDAQ Biotechnology
BIB
$79M
$223K 0.11%
+3,712
New +$211K
CBI
138
DELISTED
Chicago Bridge & Iron Nv
CBI
$222K 0.11%
+13,194
New +$202K
CI icon
139
Cigna
CI
$72.9B
$221K 0.11%
1,184
– –
AVGO icon
140
Broadcom
AVGO
$1.95T
$220K 0.1%
+9,070
New +$224K
DAL icon
141
Delta Air Lines
DAL
$60.9B
$214K 0.1%
4,444
-467
-10% -$23.3K
EFX icon
142
Equifax
EFX
$20.4B
$212K 0.1%
+2,000
New +$264K
WDC icon
143
Western Digital
WDC
$188B
$209K 0.1%
3,192
-52
-2% -$3.45K
INTU icon
144
Intuit
INTU
$87.3B
$208K 0.1%
+1,462
New +$202K
IJS icon
145
iShares S&P Small-Cap 600 Value ETF
IJS
$8.34B
$205K 0.1%
+2,776
New +$194K
SU icon
146
Suncor Energy
SU
$76.7B
$205K 0.1%
+5,913
New +$189K
KMB icon
147
Kimberly-Clark
KMB
$35.9B
$202K 0.1%
1,730
-20
-1% -$2.44K
JE
148
DELISTED
Just Energy Group Inc
JE
$198K 0.09%
1,036
– –
BCS icon
149
Barclays
BCS
$95.1B
$189K 0.09%
19,197
-82
-0.4% -$813
JBLU icon
150
JetBlue
JBLU
$2.46B
$188K 0.09%
10,174
-1,789
-15% -$37.5K
4 5
6
7 8

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
SCP
Seizert Capital Partners Birmingham, Michigan $2.17B AUM 11.2% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
MMLI
Massachusetts Mutual Life Insurance Springfield, Massachusetts $2.17B AUM 48.68% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM

Traynor Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Traynor Capital Management held 178 positions worth $210M, up 3.8% from $203M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Traynor Capital Management's Q3 2017 filing shows 16 new, 72 increased, 69 reduced and 10 closed positions. Its largest new stake was Teva Pharmaceuticals: 19,502 shares worth $335K. The largest sale was Alnylam Pharmaceuticals, an estimated $516K.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Communication Services and Healthcare.

  • Traynor Capital Management's largest Q3 2017 buy was Teva Pharmaceuticals: 19,502 shares worth $335K.
  • Traynor Capital Management added most to Intuitive Surgical in Q3 2017, an estimated $840K increase.
  • Traynor Capital Management's biggest Q3 2017 reduction was Amazon, cutting an estimated $363K.
  • Traynor Capital Management fully exited Alnylam Pharmaceuticals in Q3 2017, selling an estimated $516K.
  • Traynor Capital Management's ten largest holdings make up 44% of its $210M portfolio in Q3 2017.
  • Traynor Capital Management opened 16 new positions and closed 10 in Q3 2017.
  • Traynor Capital Management's portfolio value rose 3.8% quarter-over-quarter to $210M.

Based on Traynor Capital Management's 13F filing for Q3 2017, filed 27 Oct 2017.